AVAILABLE THE LATEST ADVANCED TESTING PROTOCOL and REQUIRED A.V.D. FOR ACQUIRED EXTENDED USE PLAQUINAL MACULAR TOXICITY ASSESSMENT (case by case basis and not a screening)
*Family Physician referral not required but encouraged In instances of prolonged use or levels in excess of 200mg daily.shutterstock_157206674
Contracted Genetic Testing of Macular Degeneration] to infer potential disease penetrance in one’s life time which may contribute to earlier recognition and therefore alignment with future research trials as they come on line anywhere in the world.